ERC1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.241200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.351800E-01
Normal-vs-Stage2
8.905000E-01
Normal-vs-Stage3
6.029900E-02
Normal-vs-Stage4
8.530400E-01
Stage1-vs-Stage2
7.436800E-01
Stage1-vs-Stage3
4.470400E-02
Stage1-vs-Stage4
4.214400E-01
Stage2-vs-Stage3
5.036300E-03
Stage2-vs-Stage4
7.802600E-01
Stage3-vs-Stage4
1.813550E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.472200E-01
Normal-vs-AfricanAmerican
8.019800E-01
Normal-vs-Asian
2.780800E-01
Caucasian-vs-AfricanAmerican
7.473800E-01
Caucasian-vs-Asian
7.492300E-02
AfricanAmerican-vs-Asian
9.956300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.712600E-01
Normal-vs-Female
6.039600E-01
Male-vs-Female
2.048800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.668400E-01
Normal-vs-Age(41-60Yrs)
8.902200E-01
Normal-vs-Age(61-80Yrs)
9.520000E-01
Normal-vs-Age(81-100Yrs)
5.297600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.458600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.788800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.509400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.915200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.989800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.858000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.131600E-01
Normal-vs-Daily Drinker
1.823240E-01
Normal-vs-Weekly Drinker
4.948400E-01
Normal-vs-Occasional Drinker
8.001200E-01
Normal-vs-Social Drinker
6.409600E-01
Non Drinker-vs-Daily Drinker
3.856200E-01
Non Drinker-vs-Weekly Drinker
9.429800E-01
Non Drinker-vs-Occasional Drinker
5.195200E-01
Non Drinker-vs-Social Drinker
6.988100E-02
Daily Drinker-vs-Weekly Drinker
4.379800E-01
Daily Drinker-vs-Occasional Drinker
9.066200E-02
Daily Drinker-vs-Social Drinker
1.128200E-02
Weekly Drinker-vs-Occasional Drinker
4.659800E-01
Weekly Drinker-vs-Social Drinker
7.065700E-02
Occasional Drinker-vs-Social Drinker
1.940210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.671000E-01
Normal-vs-Grade 2
2.701000E-01
Normal-vs-Grade 3
3.736200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.716200E-01
Grade 1-vs-Grade 3
2.701200E-01
Grade 1-vs-Grade 4
3.671000E-01
Grade 2-vs-Grade 3
9.570600E-01
Grade 2-vs-Grade 4
2.701000E-01
Grade 3-vs-Grade 4
3.736200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.131800E-01
Normal-vs-NonDiabetic
8.519600E-01
Diabetic-vs-NonDiabetic
9.447000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.398000E-01
Normal-vs-NoPancreatitis
8.724000E-01
Pancreatitis-vs-NoPancreatitis
8.298400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.155800E-01
Normal-vs-N1
9.026000E-01
N0-vs-N1
9.459400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.225600E-01
Normal-vs-TP53-NonMutant
8.305200E-01
TP53-Mutant-vs-TP53-NonMutant
2.927800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
